Until vaccines against COVID-19 become available, ‘testing, testing and more testing’ to support the detection of cases and isolation of patients is the only effective strategy against the disease.
Kunal Jain, from IMAP India’s team, summarises the pharmaceutical progress on treatments for Covid-19 and highlights from a recent virtual conference on this subject in Israel the steps being taken across the world on a possible cure to halt the spread of the virus.
IMPROMAT-COMPUTER, serves large corporate clients in the Telecommunications, Utilities, Banking, Insurance, and Industrial sectors. It has over 100 employees and generates €34 million in revenues
Khell-Food is the largest producer of ready-made sandwiches and baguettes in the Hungarian market
IMAP partners are now operating in a market that is transitioning away from a phase of cheap financing, pent-up demand and high valuations to one of surging inflation, rising interest rates, more selective investor appetite, and widespread domino effects from the war in Ukraine.
